ICCC
$5.70
Immucell Cp
$.02
.35%
ICCC
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $0.00
Revenue:  $0.00 Mil
Thursday
Nov 12
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ICCC reports earnings?
Beat
Meet
Miss

Where is ICCC's stock price going from here?
Up
Flat
Down
Stock chart of ICCC
Analysts
Summary of analysts' recommendations for ICCC
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibody technology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.